LULU › analyze
LULU · Analyze
2026-08-11 · $126.01 · Mkt cap $14.31B · EV $15.13B · Consumer Cyclical / Apparel Retail
Verdict up front
WATCH — conviction 5.0 / 10. Do not front-run the September print.
Lululemon is genuinely cheap on trailing numbers — 10.2× trailing earnings, 54% gross margin, net cash, 10.6% of the share count retired in eighteen months — and it is genuinely broken on trend: five consecutive quarters of declining Americas comps, an admitted product failure, a one-market growth engine that just insulted that market, and a full-price norm being spent down on markdowns. The framework's own test applies directly: great company + cheap = value; poor company + cheap = value trap, and the honest answer is that the evidence for which one this is arrives on ~September 3rd, delivered by a brand-new CEO with every incentive to reset guidance downward on her first day. Waiting costs nothing here. Buying does.
1. Fundamentals
Fiscal year ends late January. FY26 = year ended 2026-01-31.
| $M | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | 8,110 | 9,620 | 10,590 | 11,100 |
| Gross profit | 4,490 | 5,610 | 6,270 | 6,280 |
| Operating income | 1,730 | 2,210 | 2,510 | 2,210 |
| Net income | 855 | 1,550 | 1,810 | 1,580 |
| EPS (dil) | 6.68 | 12.20 | 14.64 | 13.26 |
| OCF | 966 | 2,300 | 2,270 | 1,600 |
| Capex | (639) | (652) | (689) | (681) |
| FCF | 328 | 1,640 | 1,580 | 922 |
| Buybacks | (444) | (559) | (1,640) | (1,180) |
| Diluted shares (M) | 128.0 | 127.1 | 123.9 | 119.1 |
CAGRs (3yr): Revenue +11.0% · Net income +22.7% · FCF +41.1% · Shares −2.4%/yr
Those CAGRs are worthless and it is important to say so. They measure from a depressed FY23 base and every one of them is negative over the most recent year: revenue +4.8% but operating income −12%, net income −13%, EPS −9%, and FCF −42% (1,580 → 922).
The single most important number in this report: free cash flow fell 42% in FY26 while revenue grew 4.8%. The trailing P/E of 10.2× hides it entirely, because the P/E is computed on earnings that fell 13% while cash earnings fell 42%. OCF dropped from $2.27B to $1.60B on flat capex.
Per-share (FY26): Revenue/share $93.25 · FCF/share $7.91 on the year-end count, $8.50 on the current 108.44M shares → 14.8× P/FCF · BVPS $42.17 → P/B 2.99×
Note the gap: 10.2× earnings but 14.8× free cash flow. When those two diverge that far, the cash number is the honest one.
Balance sheet — a real strength and the bull case's foundation. Assets $8.46B, liabilities $3.49B, equity $4.96B. Reported debt of $1.80B is operating lease liabilities, not borrowings — Lululemon has no meaningful financial debt and holds $1.81B of cash, so it is roughly net cash. Debt/assets 21.3%; current ratio 2.23. This company cannot be forced into anything by a lender. That matters enormously in a turnaround.
Capital allocation. Shares outstanding went 126.22M → 121.28M → 116.50M → 108.44M today — a 10.6% reduction in eighteen months, ~$1B of authorization remaining. But FY26 buybacks of $1.18B exceeded FCF of $922M, and cash fell from $1.98B to $1.81B. They are buying back stock faster than the business generates cash, which is defensible at a depressed price with $1.8B in the bank and is not indefinitely sustainable if FCF stays at $900M. Capex is $681M (6.1% of revenue) funding store growth, chiefly in China. No dividend.
Scorecard: balance sheet A · gross margin level A · revenue growth C+ · cash-flow trend F · margin trajectory D · capital allocation B (aggressive, arguably correct, mildly over-extended). Flagged gaps: FY22 absent from the feed; exact buyback authorization size and date unverified against the 10-Q.
2. Q1 FY26 and the guidance reset
Q2 FY26 is NOT yet reported. The quarter ended ~August 2; the print is expected September 3–4, 2026 ⚠️ (one source says Aug 27 — verify on IR). Latest actuals are Q1 FY26, reported June 4.
Q1 FY26 (quarter ended 2026-05-03): Revenue $2.5B, +4% (+2% cc). Global comps −2%. Gross margin 54.2%, −410bps. Operating income $276.9M, −37%. Diluted EPS $1.69 vs $2.60.
| Region | Revenue | Comps (cc) |
|---|---|---|
| Americas | $1.6B, −3% (−4% cc) | −6% ⚠️ (−5% in some sources) |
| China Mainland | +30% (+23% cc) | +13% — but 8pts from Chinese New Year timing |
| Rest of World | +13% (+9% cc) | +1% |
China is now 19% of revenue, up from 16%.
Tariffs: −280bps to Q1 product margin, with ~100bps recovered through efficiency → ~180bps net. The FY25 10-K quantified ~$275M of unmitigated annual gross-profit exposure from US tariffs plus de minimis removal.
The guidance cut (June 4) — revenue to $11.0–11.15B from $11.35–11.50B; EPS to $10.95–11.15 from $12.10–12.30, against $13.26 delivered the prior year. North America revenue guided −1% to −3%; Americas comps guided down high single digits; China ~+20%. ⚠️ Only this one revision cycle is confirmed; earlier FY26 cuts may exist.
Correct the multiple. At $126.01 on guided EPS of ~$11.05 this is 11.4× forward, not
10×. And per Knowledge/Playbook/pitfall-forward-pe-above-trailing-pe-flags-an-inflated-base
run in reverse: forward P/E above trailing P/E means the E is falling, not that the stock
got cheaper. You are paying a higher multiple on a lower number.
3. Moat — and the specific thing that is breaking
Quantitative base. Gross margin 56.6% trailing / 54.2% in Q1, versus 55.4% four years ago — still elite for apparel, but −410bps year over year is the largest single-quarter compression in the company's public history. ROE 32%, ROIC = NOPAT ($2.21B × 0.75 ≈ $1.66B) / invested capital $4.96B = ~33%, down from ~40% at peak. These are still outstanding returns. They are declining.
| Moat source | Assessment |
|---|---|
| Brand / intangibles | The whole moat — and it is eroding |
| Fabric & fit engineering (Luon, Nulu, Align) | Commoditised — Alo and Vuori ship comparable product |
| Community / store-as-studio distribution | Physically contested — rivals open next door on purpose |
| The full-price norm | Actively being spent down |
| Switching costs | Zero. Apparel has none |
| Network effects / scale cost advantage | None meaningful |
Adversarial stress-test — and it is already happening, which is the point. There is no patent, no lock-in, no switching cost, and no network effect defending this business. What defended it was a bundle of three things, and all three are under attack simultaneously:
- Fabric and fit. Genuinely differentiated for a decade; now matched. Alo Yoga and Vuori ship comparable technical product at comparable prices.
- Community and store placement. Alo (~99 US stores) and Vuori (93 locations, >$5B valuation, preparing a 2026 IPO) deliberately open adjacent to Lululemon stores. Nike is recovering and has partnered with Skims on womenswear — itself an admission that Nike could not win athleisure alone.
- The full-price norm — and this is the one that matters. Once a premium brand teaches customers to wait for "We Made Too Much," the price point resets downward and does not easily come back. Management concedes markdowns improve only "modestly" in FY26, with year-over-year decreases not appearing until 2H26. The discounting is running now.
Share loss is real; the magnitude is contested. DTC channel share fell from 30% (Jan 2025) to 24% (Nov). A foot-traffic dataset shows LULU's share of a tracked set falling 86.5% → 77.5% with Alo rising 1.4% → 8.6% ⚠️ (PassBy — small tracked universe, directional only; a separate source claims LULU is still gaining share, so these datasets contradict each other). Alo's share is variously cited at 8% → 12% → 14% across Sept/Oct/Nov. Vuori roughly flat ~5%. On roughly flat. Treat the direction as established and the magnitude as unverified.
Self-inflicted, by management's own account. CEO McDonald admitted the brand had become "too predictable within our casual offerings," that lounge/social assortments had gone "stale," and that seasonal colours were rejected. When styles did work, Lululemon could not chase demand fast enough. The fix: raise new styles to 35% of the assortment by spring 2027, from 23%.
This is a merchandising fix, not a moat repair. It is the right thing to do, and it says the deterioration is internal — recoverable in principle, but requiring a design culture the company has not produced for two years.
One genuinely important counter-signal: inventory is clean. Dollars up mid-to-high single digits, units flat to slightly down; Q1 units +6%, below guidance. A melting brand shows bloated inventory. This one does not. The gross-margin damage is tariffs plus deliberate markdowns — not a glut. That single fact is the strongest evidence that this is a merchandising stumble rather than a demand break, and it is why the bull case is not dismissible.
Evergreen rating: 5/10. Premium athleisure endures. That Lululemon commands the premium is the question, and the answer is currently trending the wrong way.
4. China — the offset just cracked
China grew 30% (+13% comps) and is guided ~+20% for the year at 19% of revenue. But 8 of those 13 comp points were Chinese New Year timing — underlying comps are roughly +5%, far weaker than the headline and decelerating.
Then on May 30 Lululemon staged a 2,000-person Great Wall yoga festival using a Japanese taiko drum. Chinese social media erupted over the cultural misstep; the company publicly apologised and pulled the materials (June 17–18).
Assessment: China remains the offset, but it is now a de-risked-only-on-paper offset. Decelerating underlying comps, plus a live brand-damage event, plus rising concentration in the one market carrying the story, plus general geopolitical exposure. If China decelerates toward its true ~5% underlying rate while the Americas stay negative, total revenue goes negative.
5. Sentiment
Leadership — the biggest change, and it lands on top of the print. Calvin McDonald is out. Heidi O'Neill, a ~30-year Nike veteran, was named CEO in April and starts September 2026. CFO Meghan Frank served as interim co-CEO from January 2026. That means the entire guidance-cut period was managed through a leadership vacuum, and the incoming CEO arrives within days of the Q2 print with maximum incentive and maximum licence to reset expectations downward. Kitchen-sink risk here is not a tail scenario; it is the base case.
Chip Wilson / proxy fight — settled, uneasily. The founder attacked the board over a "third failed succession planning process," called McDonald "lacking vision," and dismissed O'Neill on the grounds that a Nike lifer "is not the symbol of transformative, creative-first leadership." Lululemon publicly called his ideas "misguided" (May 18). Settlement: Marc Maurer and Laura Gentile joined the board after the June 25 meeting, with one more product/brand director due by 2026-10-01 — a fresh flashpoint on the calendar.
Analysts — heavily negative. Truist → Hold. BNP Paribas → Underperform, $88. One sell rating at $94. Baird cut to $225 from $260 (older, pre-collapse). Consensus targets vary wildly by aggregator: ~$138–148 in one set, ~$115 in a post-Q1 batch, and Yahoo shows $127.92 — essentially the current price — with a hold recommendation.
Short interest ~9.85M shares, ~8.67% of shares outstanding ⚠️ (date unconfirmed) — elevated for a large cap.
The notable bull: Michael Burry opened LULU in the Q1 2026 13F at ~$106.9M, among his largest positions, and confirmed no sales as of a July 30 post. ⚠️ One source describes a "Q3 13F" doubling 50k→100k shares — garbled and inconsistent with the $106.9M figure; disregard that detail. No insider buying found ⚠️ (unverified — Form 4s not checked directly).
6. Valuation
Company type: consumer cyclical with a brand question, no dividend, net cash. DDM and DYT are N/A. Weight Graham (real book value, profitable), FCF-based multiples, and scenario analysis on the earnings trough.
Multiples: P/E(ttm) 10.2× · P/E(fwd) 11.4× (on guided $11.05) · P/FCF 14.8× · EV/EBITDA 5.90× · EV/Revenue 1.35× · P/B 2.99× · PEG 0.98 · No dividend
Note the ordering: forward P/E is above trailing P/E, which flags a falling earnings base rather than a cheapening stock. And P/FCF at 14.8× is 45% above the headline P/E — the cash number tells a materially less attractive story than the earnings number, and the cash number is the one that funds buybacks.
Graham IV — √(22.5 × 12.35 × 42.17) = $108.25 on trailing EPS. On guided FY27 EPS of $11.05: √(22.5 × 11.05 × 42.17) = $102.40. Graham says the stock is 16–23% above fair value, and unlike the asset-light services names in today's batch, Graham has real footing here — Lululemon has genuine book value in inventory, stores and cash. This is the single most important valuation datapoint in the report, and it argues against the "it's obviously cheap" reflex.
EV/EBITDA of 5.90× looks compelling for a 54%-gross-margin brand. It is computed on trailing EBITDA that is falling.
Bogle expected return: 0% dividend + ~5–7% share retirement + earnings growth that is currently negative ± multiple change. Until EPS stops falling, Bogle produces a negative expected return before any re-rating. The entire return depends on where the earnings trough is — which is exactly the thing nobody can know before September.
Reverse-DCF — what is priced in? At EV $15.13B against ~$900M of FCF, a 9% discount rate implies the market expects roughly 1–2% annual FCF growth in perpetuity. That is neither optimistic nor punitive. The market is pricing a stabilised, no-growth Lululemon. It is not pricing a recovery, and it is not pricing a collapse. The stock is therefore a coin-flip on which of those two happens — which is precisely a conviction-5 setup.
Fair value range: $95.00 – $150.00, centre ~$120. - Bear $95 — 9× a further-reset EPS of ~$10.50; O'Neill kitchen-sinks guidance, Americas comps stay negative through FY27, China decelerates to its underlying ~5%, markdowns become structural. - Base $120 — 11× $11.05; the newness push arrests the Americas decline through 2027 without restoring growth, tariffs persist, buyback carries per-share value. - Bull $150 — 13–14× a recovering ~$11.50–12.00 in FY28; newness at 35% works, full-price selling returns in 2H27, tariffs ease, China holds ~15%+, and a ~5%/yr share retirement compounds on top.
At $126.01 the stock sits above the centre of the range, and above Graham on both trailing and forward earnings.
7. Tensions and the debate round
This name has the sharpest internal disagreement of the seven, so run it explicitly.
Moat vs. Fundamentals. Moat says five consecutive quarters of Americas comp decline, a zero-switching-cost category, two better-positioned rivals opening stores next door, and a full-price norm being spent down — the defence is weakening and the fix is merchandising, not moat. Fundamentals replies with 54% gross margin, ~33% ROIC, net cash, and clean inventory — units flat to down, which is not what a melting brand looks like.
Resolution: Moat owns the trend, Fundamentals owns the balance sheet and the inventory. The decisive question is narrow and answerable: can the full-price norm be restored? Clean inventory says the merchandise is not piling up. Management's own markdown guidance says discounting still runs through 2H26. Nothing in the Q1 data proves it can be restored yet.
Valuation vs. Valuation. EV/EBITDA at 5.90× and a trailing P/E of 10.2× say deep value. Graham at $102–108 and P/FCF at 14.8× say fully priced to modestly expensive. Resolution: Graham and P/FCF win. The low P/E and low EV/EBITDA are both computed on trailing numbers that are falling; Graham incorporates book value and is the more stable anchor, and free cash flow is what actually funds the buyback carrying the per-share story. A 42% FCF decline disqualifies the "obviously cheap" reading.
Sentiment vs. everything. A brand-new CEO arriving days before or after the print is not a neutral fact — it is a specific, dateable, high-probability negative catalyst. Even a bull should want to buy after it.
The strongest bear case, stated fully. Five straight quarters of Americas comp decline is a trend, not a cycle. The core market is ~65% of revenue and shrinking while two better-positioned challengers take the young customer who defines the category's future — customers who, per reporting, describe Lululemon as "their mother's yoga brand." Management admitted the product was stale, so the deterioration is internal and requires a design culture the company has not produced for two years. The one growth engine is a single geopolitically-exposed country whose reported comp is half calendar timing and which the company just offended. The full-price norm — the actual moat — is being spent down. Tariffs take ~$275M off gross profit structurally. 11.4× a falling E is not cheap; it is a value trap where the E keeps resetting.
The strongest bull case, stated fully. Revenue still grew 4.8% and gross margin is 54.2% — a level most apparel companies never reach. This is a damaged quarter at a structurally superior business, not a broken one. The EPS collapse is dominated by tariffs (~280bps), an exogenous and potentially transient policy cost, not lost demand, plus markdowns management is actively unwinding into 2H26. Inventory is clean, which is the tell that separates a merchandising stumble from a real demand break. The problem is diagnosed and specific (newness 23% → 35%). The board fight is settled with product-expertise directors added. A proven Nike operator arrives in September with $1B of authorization retiring ~5% of shares annually into a depressed price, $1.8B of cash, and no debt. China at 19% and ~20% growth is a real second engine. Michael Burry's ~$107M position is an explicit bet that pessimism has pushed the price below long-term earning power.
My read: the bear owns the trend, the bull owns the balance sheet, and neither owns September.
8. Risks
- New-CEO kitchen sink — O'Neill starts September, around the Q2 print. High probability of a further guidance reset. This is the nearest-term and most likely risk.
- Tariffs / sourcing concentration — Vietnam ~40%, Cambodia ~18%, Sri Lanka ~11%, Indonesia ~11% of manufacturing; cited rates Cambodia 49%, Sri Lanka 44%, Indonesia 32% ⚠️ (rates and sourcing mix conflict across sources — one gives Cambodia 9% / Sri Lanka 11%; verify against the 10-K. No Vietnam rate confirmed.) ~$275M unmitigated annual hit.
- Americas comps failing to inflect in 2H26 despite the newness push — a sixth and seventh negative quarter would confirm structural share loss.
- China deceleration plus Great Wall fallout — 19% of revenue, underlying comp already ~+5%.
- Permanent price-point reset from sustained markdowns — the hardest damage to reverse.
- Free cash flow down 42% while buybacks exceed FCF and draw down cash.
- Wilson re-escalation — the settlement is a truce; the Oct 1 director appointment is a scheduled flashpoint.
- Vuori IPO funding an accelerated store rollout directly against Lululemon.
- Zero switching costs — structural, permanent, and the reason apparel moats decay quickly once brand heat turns.
A portfolio-specific passage was removed from the public build.
10. Verdict
WATCH — conviction 5.0 / 10. Fair value $95–150, centre $120. Entry $100–110. Trim at 16× forward earnings.
Apply the framework's first principle honestly. Is this a good business? It was unambiguously; it currently has elite gross margins, ~33% ROIC, a fortress balance sheet, and clean inventory — alongside five straight quarters of core-market comp decline and a self-admitted product failure. Has the market priced it? Graham says fair value is $102–108, free cash flow says 14.8×, and the reverse-DCF says the market already assumes a stabilised, no-growth Lululemon. The stock is not cheap enough to compensate for an unresolved brand question.
The specific reason to wait is dateable: a new CEO arrives in September, within days of the Q2 print, with every professional incentive to reset the bar low and own the recovery. That is the highest-probability negative catalyst in today's entire batch, and it is roughly three weeks away. If it produces a reset toward $100–110, this becomes an interesting entry into a franchise with a real balance sheet and a specific, diagnosed, fixable problem. Buying ahead of it is paying full Graham value for the privilege of taking that risk first.
What would change the rating: Americas comps inflecting positive → upgrade toward 6.5 · markdown levels declining year-over-year in 2H26 → upgrade · China underlying comps holding above 10% ex-timing → upgrade · a sixth negative Americas quarter with further guidance cuts → downgrade toward 3.5 and treat as structural · the price below $110 post-print with the thesis intact → the entry.
Next check: Q2 FY26 print, ~September 3–4, 2026 ⚠️ (verify date on IR).